Clinical Trial

Cerebral Microembolization During Pulmonary Vein Isolation: Comparison of Different Pulsed Field Ablation Systems

Study acronym: MICROPFA
Not Yet Recruiting
View on ClinicalTrials.gov →
Summary
This prospective, randomized, parallel-group interventional study will compare cerebral microembolization during pulmonary vein isolation between different pulsed field ablation systems in patients with paroxysmal or persistent atrial fibrillation. Adult patients with an indication for catheter ablation will be randomized to one of the included ablation systems: PulseSelect, Varipulse, Farapulse, Sphere-9, or Sphere-360. Microembolic signals will be assessed using transcranial Doppler before and after the procedure. The primary outcome will be the difference in the change in microembolic signal burden, expressed as ΔMES, between the different ablation systems.
Trial Details
NCT Number NCT07610018
Lead Sponsor Ivan Zeljkovic
Collaborators: University Hospital Dubrava, University Hospital Center Sisters of Charity, Zagreb, Croatia
Conditions Ablation of Arrhythmia's
Enrollment 100 participants
Start Date 2026-06-01
Primary Completion 2027-01-01 (estimated)
Study Completion 2027-01-20 (estimated)
Updated on ClinicalTrials.gov 2026-05-27